JOIN THE PRADAXA SUPPORT PROGRAM

SIGN UP FOR SUPPORT, INFORMATION, AND SAVINGS

  • FOR PRADAXA PATIENTS
  • HOW TO TAKE PRADAXA
  • SAFETY & SIDE EFFECTS
  • JOIN THE PRADAXA SUPPORT PROGRAM
  • MEDICATON REMINDERS

Join The New Housecall™ support program from the makers of PRADAXA—designed to provide you with information and support.

Sign up now and you’ll gain FREE access to:

  • Helpful information about taking PRADAXA, plus valuable insights about living with atrial fibrillation (or AFib) not caused by a heart valve problem.
  • Optional medication reminders delivered via mail, email, or phone.
  • Valuable savings on your PRADAXA prescription— Download the PRADAXA Savings Card and you could be eligible to save on your prescription or get one FREE 30-Day supply of PRADAXA.* It's available instantly for download right after you sign up.

Step 1 of 3: Join The New Housecall™ support program by PRADAXA.

First name*
Last name*
Email address
Address*
City*
State/Territory*
Zip Code*
Telephone
Date of Birth*
This offer is only valid for U.S. residents who are 18 years of age or older.
continue

Please complete the following survey so we can provide customized information specifically for you.

WHAT IS PRADAXA?

PRADAXA is a prescription blood-thinning medicine used to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem. With atrial fibrillation, part of the heart does not beat the way it should. This can cause blood clots to form, increasing your risk of a stroke. PRADAXA lowers the chance of blood clots forming in your body.

1. Which of the following best describes you?
My doctor has diagnosed me with atrial fibrillation (or AFib) I care for someone who has been diagnosed with atrial fibrillation (or AFib)
2. Are you currently taking or were you just prescribed PRADAXA?
Yes No
3. Have you previously taken a prescription medicine and/or nonprescription medicine to reduce the risk of stroke due to atrial fibrillation
I have previously taken a prescription medicine. I have previously taken a nonprescription medicine. I have previously taken both. I have previously taken no medicine for this condition.
"Please fill out the questions below only if you have NOT been prescribed PRADAXA. If you have been prescribed PRADAXA, please click “Yes” above." 3. Which statement best describes you?
I am resistant or reluctant to see a doctor about symptoms I’m experiencing. If I hear about a new medicine that I feel is right for me, I am likely to ask my doctor to prescribe it for me/convert me to it if it is appropriate. I feel like I get enough information from my doctor about my medications.
4. Are you taking a prescription medicine and/or nonprescription medicine to reduce the risk of stroke due to atrial fibrillation?
I am currently taking a prescription medicine. I am currently taking a nonprescription medicine. I am currently taking both. I am currently taking no medicine for this condition.
5. Which of the following best describes you? Please choose only ONE.
"I frequently search for the latest information about my health." "My heart condition has limited my physical activities and ability to do things I enjoy." "With my health, I feel like a burden to those around me." "I have atrial fibrillation, but I don’t think taking medicine is worth the hassle." "I feel healthy and my risk of stroke from atrial fibrillation is low, so I don’t need to treat it."
2. Is your loved one currently taking PRADAXA, or was he or she just prescribed PRADAXA?
Yes No
3. Do you live with your loved one whom you care for?
Yes No
4. What is your relationship to your loved one?
Sibling Spouse/Partner Child Friend Caregiver Other
5. Does your loved one sometimes forget to take his or her medication?
Yes No
5A. How often does your loved one forget to take his or her medication?
Once a day. 1 to 2 times a week. 1 to 2 times a month.
6. What worries you most about your loved one? Please check all that apply.
"I worry that if my loved one feels good, he or she may stop taking medicine." "I worry I will not be there for my loved one when he or she needs me." "I worry that I’m not as involved in my loved one’s health as I should be." "I worry that I’m not as educated about my loved one’s illness as I could be." "I don’t worry often about my loved one."
"Please fill out the questions below only if your loved one has NOT been prescribed PRADAXA. If your loved one has been prescribed PRADAXA, please click “Yes” above." 3. Has your loved one ever taken a prescription medicine and/or nonprescription medicine to reduce the risk of stroke due to atrial fibrillation?
My loved one is currently taking a prescription medicine. My loved one is currently taking a nonprescription medicine. My loved one is currently taking both. My loved one is currently taking no medicine for this condition.
4. How close do you feel to the person in your life with atrial fibrillation?
I’m very close. I’m somewhat close. I’m not really close. I’m not at all close.
5. Which of the following best describes you? Please choose only ONE.
"I frequently search for the latest information about new medicines for my loved one." "I rely on my loved one to seek out new information on medicines." "I’m too stressed with managing my life to search for information about new medicines." "Atrial fibrillation doesn’t concern me enough to spend time looking for information about it."
continue
Thank you for your patience. We’re almost finished. Don’t forget to click “SUBMIT” to complete the sign-up process.

How would you prefer to receive future communications?
Email Direct Mail
By checking here, you indicate that you agree to our Privacy Statement and allow us to use your information to advertise PRADAXA and other products to you. Boehringer Ingelheim may also provide you with useful materials and contact you about health-related topics.

If you do not check the box, you will only receive the materials you requested, and will not receive any ongoing communications.

The information you are providing will be used by Boehringer Ingelheim Pharmaceuticals, Inc., so that we may advertise our products to you and provide you with information about them.

We respect your right to have personal and medical information kept confidential. Companies working with us will use the information you provide to send you information, seek your opinions, and help develop products, services, and programs. If we provide you with coupons or vouchers for our products, the information we receive from the pharmacy regarding their use will also be used for the same purposes.

We won’t share your private information with anyone else, including mailing lists.

This offer is only valid for U.S. residents who are 18 years of age or older.

submit

SEND TO A FRIEND
NOT CURRENTLY TAKING PRADAXA, BUT WANT TO LEARN MORE?

Sign up now to receive more information about PRADAXA, AFib that's not caused by a heart valve problem, and the stroke risk associated with AFib.

SIGN UP 

The information you provide will only be used by Boehringer Ingelheim Pharmaceuticals Inc., and its vendors, and will not be distributed. You can opt out or change your settings any time.

* Pay no more than $30 if you have commercial insurance, with a maximum benefit of $100 on your monthly prescription over a 12-month period. If you are covered by a government-funded insurance, or are cash paying, or live in the state of Massachusetts, you are eligible for one FREE 30-day supply of PRADAXA.

PRADAXA® (DABIGATRAN ETEXILATE MESYLATE) CAPSULES:
IMPORTANT STORAGE AND HANDLING INFORMATION
PRADAXA must be kept dry. To protect it from moisture, PRADAXA comes in either a bottle with a special cap that contains a drying agent or a blister pack with each capsule sealed separately.

When taking PRADAXA, please follow these instructions carefully:
  • Always store PRADAXA in its original container.
    • Never put PRADAXA into any other container, such as a pill box or pill organizer.
    • Store PRADAXA at room temperature between 59°F to 86°F (15°C to 30°C).
  • If your PRADAXA came in a bottle:
    • Be sure the closure tape, which indicates that the bottle has not been opened, is intact when you receive your prescription. Do not remove the closure tape until you are ready to open the bottle. Open your new bottle only after finishing your current bottle.
    • Once the bottle is opened, you must use PRADAXA within 30 days.
      • As soon as you open the bottle, write the date on the label. PRADAXA will expire 30 days after the date you opened the bottle.
      • Do not alter the child-proof cap.
      • Safely throw away any unused PRADAXA after 30 days.
      • If your pharmacist or other healthcare provider gave you more than one bottle of PRADAXA, be sure to open only one bottle at a time.
    • Each time you take PRADAXA:
      • Remove only one capsule from the opened bottle.
      • Immediately and tightly close the bottle.
  • If your PRADAXA came in a blister pack, remove only one capsule from the pack at a time.
  • Always read the Medication Guide included with each of your PRADAXA prescriptions. There may be information that is new or that has changed since your last prescription.
  • Remember to keep PRADAXA, and all medicines, out of the reach of children.
Not actual size


Pradaxa® is a registered trademark of Boehringer Ingelheim Pharma GmbH & Co. KG and used under license.
Copyright© 2012 Boehringer Ingelheim Pharmaceuticals, Inc. All Rights Reserved. 01/2012
PX94538CONS

Print
Close

WHAT IS PRADAXA?

PRADAXA is a prescription blood-thinning medicine used to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem. With atrial fibrillation, part of the heart does not beat the way it should. This can cause blood clots to form, increasing your risk of a stroke. PRADAXA lowers the chance of blood clots forming in your body.

 

IMPORTANT SAFETY INFORMATION ABOUT PRADAXA

PRADAXA can cause bleeding which can be serious and sometimes lead to death. Don’t take PRADAXA if you currently have abnormal bleeding or if you have ever had an allergic reaction to it.

Your risk of bleeding with PRADAXA may be higher if you:

  • • are 75 years old or older
  • • have kidney problems
  • • have stomach or intestine bleeding that is recent or keeps coming back or you have a stomach ulcer
  • • take other medicines that increase your risk of bleeding, like aspirin products, non-steroidal anti-inflammatory drugs (NSAIDs) and blood thinners
  • • have kidney problems and take dronedarone (Multaq®) or ketoconazole tablets (Nizoral®)

Call your doctor or seek immediate medical care if you have any of the following signs or symptoms of bleeding:

  • • any unexpected, severe, or uncontrollable bleeding; or bleeding that lasts a long time
  • • unusual or unexpected bruising
  • • coughing up or vomiting blood; or vomit that looks like coffee grounds
  • • pink or brown urine; red or black stools (looks like tar)
  • • unexpected pain, swelling, or joint pain
  • • headaches and feeling dizzy or weak

It is important to tell your doctor about all medicines, vitamins and supplements you take. Some of your other medicines may affect the way PRADAXA works.

Take PRADAXA exactly as prescribed by your doctor. Don’t stop taking PRADAXA without talking to your doctor as your risk of stroke may increase.

Tell your doctor if you are planning to have any surgery, or medical or dental procedure, because you may have to stop taking PRADAXA for a short time.

PRADAXA can cause indigestion, stomach upset or burning, and stomach pain.

Click here for full Prescribing Information including Medication Guide

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call
1-800-FDA-1088.

The health information contained in this Website is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.

IMPORTANT SAFETY INFORMATION ABOUT PRADAXA

Click here to expand

PRADAXA can cause bleeding which can be serious and sometimes lead to death. Don’t take PRADAXA if you currently have abnormal bleeding or if you have ever had an allergic reaction to it.


Your risk of bleeding with PRADAXA may be higher if you:

  • • are 75 years old or older
  • • have kidney problems
  • • have stomach or intestine bleeding that is recent or keeps coming back or you have a stomach ulcer
  • • take other medicines that increase your risk of bleeding, like aspirin products, non-steroidal anti-inflammatory drugs (NSAIDs) and blood thinners
  • • have kidney problems and take dronedarone (Multaq®) or ketoconazole tablets (Nizoral®)

Call your doctor or seek immediate medical care if you have any of the following signs or symptoms of bleeding:

  • • any unexpected, severe, or uncontrollable bleeding; or bleeding that lasts a long time
  • • unusual or unexpected bruising
  • • coughing up or vomiting blood; or vomit that looks like coffee grounds
  • • pink or brown urine; red or black stools (looks like tar)
  • • unexpected pain, swelling, or joint pain
  • • headaches and feeling dizzy or weak

It is important to tell your doctor about all medicines, vitamins and supplements you take. Some of your other medicines may affect the way PRADAXA works.


Take PRADAXA exactly as prescribed by your doctor. Don’t stop taking PRADAXA without talking to your doctor as your risk of stroke may increase.


Tell your doctor if you are planning to have any surgery, or medical or dental procedure, because you may have to stop taking PRADAXA for a short time.


PRADAXA can cause indigestion, stomach upset or burning, and stomach pain.



WHAT IS PRADAXA?


PRADAXA is a prescription blood-thinning medicine used to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem. With atrial fibrillation, part of the heart does not beat the way it should. This can cause blood clots to form, increasing your risk of a stroke. PRADAXA lowers the chance of blood clots forming in your body.


Click here for full Prescribing Information including Medication Guide.


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.


The health information contained in this Website is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.
CLOSE X

Please Note: You are now leaving a Boehringer Ingelheim Pharmaceuticals. Inc., site. Boehringer Ingelheim Pharmaceuticals. Inc., has not reviewed the contents of all the pages and sites that may be linked to this site. Boehringer Ingelheim Pharmaceuticals. Inc., is not responsible and disclaims any liability to the content of any other page or site or for any viruses or similar harmful programs that may be present on such pages or sites. Linking to any other page or site is at your own risk.



Your request is processing, please wait one moment...

FOR HEALTHCARE PROFESSIONALS

close
This site is intended for US healthcare
professionals only. Would you like to continue?

YES, I am a US
healthcare professional.

US

I am a healthcare professional but
am located in one of these countries

  • Spain
  • Sweden
  • Germany
  • Italy
  • Netherlands
For all other countries, click here.
NO, I am not a healthcare professional.
CLOSE X

Please Note: You are now leaving a Boehringer Ingelheim Pharmaceuticals. Inc., site. Boehringer Ingelheim Pharmaceuticals. Inc., has not reviewed the contents of all the pages and sites that may be linked to this site. Boehringer Ingelheim Pharmaceuticals. Inc., is not responsible and disclaims any liability to the content of any other page or site or for any viruses or similar harmful programs that may be present on such pages or sites. Linking to any other page or site is at your own risk.

PRADAXA® (DABIGATRAN ETEXILATE MESYLATE) CAPSULES:
IMPORTANT STORAGE AND HANDLING INFORMATION
PRADAXA must be kept dry. To protect it from moisture, PRADAXA comes in either a bottle with a special cap that contains a drying agent or a blister pack with each capsule sealed separately.

When taking PRADAXA, please follow these instructions carefully:
  • Always store PRADAXA in its original container.
    • Never put PRADAXA into any other container, such as a pill box or pill organizer.
    • Store PRADAXA at room temperature between 59°F to 86°F (15°C to 30°C).
  • If your PRADAXA came in a bottle:
    • Be sure the closure tape, which indicates that the bottle has not been opened, is intact when you receive your prescription. Do not remove the closure tape until you are ready to open the bottle. Open your new bottle only after finishing your current bottle.
    • Once the bottle is opened, you must use PRADAXA within 30 days.
      • As soon as you open the bottle, write the date on the label. PRADAXA will expire 30 days after the date you opened the bottle.
      • Do not alter the child-proof cap.
      • Safely throw away any unused PRADAXA after 30 days.
      • If your pharmacist or other healthcare provider gave you more than one bottle of PRADAXA, be sure to open only one bottle at a time.
    • Each time you take PRADAXA:
      • Remove only one capsule from the opened bottle.
      • Immediately and tightly close the bottle.
  • If your PRADAXA came in a blister pack, remove only one capsule from the pack at a time.
  • Always read the Medication Guide included with each of your PRADAXA prescriptions. There may be information that is new or that has changed since your last prescription.
  • Remember to keep PRADAXA, and all medicines, out of the reach of children.
Not actual size


Pradaxa® is a registered trademark of Boehringer Ingelheim Pharma GmbH & Co. KG and used under license.
Copyright© 2012 Boehringer Ingelheim Pharmaceuticals, Inc. All Rights Reserved. 01/2012
PX78537CONS

Print
Close